This announcement contains information which, prior to its disclosure, was inside information as stipulated under Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310 (as amended). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.
2/12/25
Valereum Plc
("Valereum", "VLRM" or the "Company")
Transformational USD
Valereum Plc is pleased to announce significant progress in the completion of its previously announced USD
Quorium Global Photonics SPC ("QGP") has now formally completed the establishment of Valereum QGP-SP ("V-QGP"), its dedicated segregated portfolio vehicle. This has been structured specifically to facilitate the drawdown and deployment of the USD
The establishment of V-QGP is a critical operational step towards the concluding phases of this landmark financing.
As part of the formation of V-QGP, the Company has issued 12,595,437 Ordinary Shares of
The Company is pleased to confirm that all required KYC, AML, UBO and regulatory due-diligence procedures relating to QGP, V-QGP, and the associated funding structures are well advanced, progressing smoothly and with no issues identified to date. Completion of the USD
Upon completion, the financing is expected to provide Valereum with a substantial long-term capital platform to accelerate its tokenisation, infrastructure and digital-asset initiatives.
James Bannon, Chairperson of Valereum, commented: "We are delighted to report strong progress towards completion of the
Application will be made for the 12,595,437 new Ordinary Shares, which will rank pari passu with the existing Ordinary Shares in issue, to be admitted to trading on the AQSE Growth Market ("Admission"). Dealings are expected to commence on or around 4 December 2025.
Following Admission, the Company's issued Ordinary Share capital will comprise 257,049,741 Ordinary Shares of
The Company will continue to update the market as further milestones toward completion of the USD
For further information, please contact:
|
Valereum Plc Karl Moss |
Tel: +44 7938 767319 |
|
Fortified Securities Guy Wheatley
|
Tel: +44 203 4117773 |
|
AQSE Corporate Adviser First Sentinel Corporate Finance Brian Stockbridge
|
Tel: +44 20 3855 5551 |
The Directors of the Company accept responsibility for the contents of this announcement.
Please visit the Company's website at www.vlrm.com
For more information, and the chance to have your questions directly answered by the management team, please head to our interactive investor hub via: Investor Hub.
IMPORTANT NOTICES
The Company holds cryptocurrencies or crypto assets in its treasury. Whilst the Board of Directors of the Company considers holding cryptocurrencies to be in the best interests of the Company, the Board remains aware that the financial regulator in the
The Company is neither authorised nor regulated by the FCA, and the purchase of certain cryptocurrencies are generally unregulated in the
Cryptocurrencies may present special risks to the Company's financial position. These risks include (but are not limited to): (i) the value of cryptocurrencies can be highly volatile, with value dropping as quickly as it can rise. Investors in cryptocurrencies must be prepared to lose all money invested in cryptocurrencies; (ii) the cryptocurrencies market is largely unregulated. There is a risk of losing money due to risks such as cyber-attacks, financial crime and counterparty failure; (iii) the Company may not be able to sell its cryptocurrencies at will. The ability to sell cryptocurrencies depends on various factors, including the supply and demand in the market at the relevant time. Operational failings such as technology outages, cyber-attacks and commingling of funds could cause unwanted delay; and (iv) crypto assets are characterised in some quarters by high degrees of fraud, money laundering and financial crime. Prospective investors in the Company are encouraged to do their own research before investing.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.